Literature DB >> 32622770

Implications for glycosylated compounds and their anti-cancer effects.

Ramin Pourakbari1, Sanaz Mansouri Taher2, Bashir Mosayyebi3, Mohammad Hosein Ayoubi-Joshaghani3, Hamid Ahmadi4, Leili Aghebati-Maleki5.   

Abstract

Glycosylated compounds are major secondary metabolites of plants, which have various therapeutic effects on human diseases, by acting as anti-cancer, antioxidant, and anti-inflammatory agents. Glycosylation increases stability, bioactivity, and solubility of compounds and improves their pharmacological properties. Two well-known examples of glycosylated compounds include cardiac and flavonoid, the anti-tumor activities of which have been emphasized by several studies. However, little is known about their role in the treatment or prevention of cancer. In this review, recent studies on anti-tumor properties of cardiac and flavonoid glycosides, and their mechanisms of action, have been investigated. More specifically, this review is aimed at focusing on the multifactorial properties of cardiac and flavonoid compounds as well as their correlation with signaling pathways in the treatment of cancer.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac glycoside; Flavonoid glycoside; Glycosylated compounds

Mesh:

Substances:

Year:  2020        PMID: 32622770     DOI: 10.1016/j.ijbiomac.2020.06.281

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  3 in total

Review 1.  Flavonoids a Bioactive Compound from Medicinal Plants and Its Therapeutic Applications.

Authors:  Arpita Roy; Ariba Khan; Irfan Ahmad; Saad Alghamdi; Bodour S Rajab; Ahmad O Babalghith; Mohammad Y Alshahrani; Saiful Islam; Md Rabiul Islam
Journal:  Biomed Res Int       Date:  2022-06-06       Impact factor: 3.246

Review 2.  Prognostic significance and therapeutic potentials of immune checkpoints in osteosarcoma.

Authors:  Vafa Meftahpour; Ali Aghebati-Maleki; Ali Fotouhi; Elham Safarzadeh; Leili Aghebati-Maleki
Journal:  EXCLI J       Date:  2022-01-12       Impact factor: 4.068

Review 3.  Co-stimulatory agonists: An insight into the immunotherapy of cancer.

Authors:  Ramin Pourakbari; Farnaz Hajizadeh; Forough Parhizkar; Ali Aghebati-Maleki; Sanaz Mansouri; Leili Aghebati-Maleki
Journal:  EXCLI J       Date:  2021-06-09       Impact factor: 4.068

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.